Cuproptosis in Sepsis: Cell Type-Specific Mechanisms and Clinical Prospects. [PDF]
Fang S +6 more
europepmc +1 more source
Precision targeting of FDX1-mediated cuproptosis by a ROS-responsive hydrogel for myocardial ischemia-reperfusion injury treatment. [PDF]
Hu J +8 more
europepmc +1 more source
ATF3/SLC31A1-Mediated Cuproptosis Contributes to Bortezomib-Induced Peripheral Neurotoxicity and Intervention by (-)-Epigallocatechin Gallate. [PDF]
Wang Y +6 more
europepmc +1 more source
Cuproptosis in inflammation and cancer: molecular mechanisms and therapeutic targets. [PDF]
Liu J +13 more
europepmc +1 more source
FDX1-mediated cuproptosis promotes cholestatic liver injury exacerbated by taurocholic acid-enhanced copper accumulation. [PDF]
Guo Y +14 more
europepmc +1 more source
Targeting copper death-related long non-coding RNAs: a novel strategy to overcome immunotherapy resistance in liver cancer. [PDF]
Sheng X +9 more
europepmc +1 more source
[Ursolic acid in <i>Huajie Xiaoliu</i> Formula inhibits colorectal cancer cell growth by inducing cuproptosis]. [PDF]
Jin C +7 more
europepmc +1 more source
Harnessing Cuproptosis for Antitumor Immunity: A Review of Current Evidence and Therapeutic Strategies. [PDF]
Lu I, Zhang J, Chen X, Wang XJ.
europepmc +1 more source
Prophylactic self-assembled nucleic acid hydrogel targeting retinal ganglion cell cuproptosis and microglial neuroinflammation for retinal ischemia-reperfusion injury. [PDF]
Liu S +17 more
europepmc +1 more source
m6A Modification of ATOX1 Inhibits Acute Myeloid Leukemia Progression by Promoting Cuproptosis. [PDF]
Peng J +5 more
europepmc +1 more source

